Cosopt Versus Xalatan

• Status: Completed
• Trial end date: 2005-12-01

Summary

To compare the 24-hour efficacy and safety, measured every three hours, of the dorzolamide/timolol fixed combination given twice daily versus latanoprost and placebo each given once daily.

• Phase: Phase 4

Details

• Lead Sponsor: Pharmaceutical Research Network
• Treatments: Dorzolamide; Latanoprost; Maleic acid; Timolol